Key Trends Influencing the Growth of the Contraceptive Drugs And Devices Market in 2025: Expansion Of Long-Acting Birth Control Options Through Innovative Vaginal Rings

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Contraceptive Drugs And Devices Market Through 2025?
The market for contraceptive drugs and devices has experienced significant expansion in the recent past. The market is projected to escalate from a value of $25.3 billion in 2024 to a slightly higher value of $26.98 billion in 2025, with an impressive compound annual growth rate (CAGR) of 6.7%. The marked growth during the past years is a result of various factors including population surge, heightened understanding of family planning, government-led initiatives and funding, a surge in the number of employed women, and the development in contraceptive technologies.

What's the Projected Size of the Global Contraceptive Drugs And Devices Market by 2029?
In the coming years, the contraceptive drugs and devices market is anticipated to exhibit strong growth, reaching a value of "$35.55 billion in 2029," demonstrating a compound annual growth rate (CAGR) of 7.1%. This projected growth within the forecast period is due to factors such as the rising demand for long-acting reversible contraceptives, an increased emphasis on women's reproductive health, the growing incidence of sexually transmitted infections, wider access provided by e-commerce and telehealth, supportive healthcare legislation, and insurance coverage. Notable trends projected for this time period include intelligent contraceptive devices featuring digital monitoring, biodegradable implants and patches, non-hormonal contraceptive innovations, fertility tracking apps powered by AI, and 3D printing of tailor-fit contraceptive devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/contraceptive-drugs-and-devices-global-market-report

Top Growth Drivers in the Contraceptive Drugs And Devices Industry: What's Accelerating the Market?
The contraceptive drugs and devices market is predicted to expand due to a surge in government initiatives focused on reproductive health. These initiatives aim to foster reproductive health by enhancing awareness, providing funds, and ensuring service accessibility. The increase in government initiatives is a result of the growing acknowledgment of the need to address key matters such as maternal health, family planning, and access to vital healthcare services, all of which are essential for societal progress and prosperity. Government activities related to contraceptive drugs and devices strive to provide broader access to cost-effective family planning methods, while assuring individuals possess the right resources to make knowledgeable decisions regarding their reproductive health. For instance, the Australian Government Department of Foreign Affairs and Trade, an Australia-based government agency, revealed in November 2024 their plan to allot $56.8 million towards a fresh initiative focused on advocating sexual and reproductive health and rights in Southeast Asia. Hence, the increase in government initiatives surrounding reproductive health is a key driver in the growth of the contraceptive drugs and devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Contraceptive Drugs And Devices Market?
Significant players within the contraceptive drugs and devices market, such as Xiromed LLC, are focusing on innovation for product improvement. They are introducing products like contraceptive vaginal rings that provide extended duration contraception and increased user-friendliness. The birth control vaginal ring is a flexible device that releases hormones to prevent ovulation, consequently avoiding pregnancy. In October 2023, Xiromed LLC based in the US, introduced the EnilloRing - a flexible, soft contraceptive vaginal ring that subtly releases a mixture of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) for a period of three weeks to stop ovulation. The EnilloRing, a bioequivalent generic to NuvaRing, is a discreet, convenient, and budget-friendly monthly contraceptive that restricts the necessity for daily intake, while still retaining the same level of safety, effectiveness, and tolerance as its branded counterpart.

What Are the Main Segments in the Contraceptive Drugs And Devices Market?
The contraceptive drugs and devices market covered in this report is segmented -

1) By Product: Contraceptive Drugs, Contraceptive Devices
2) By Technology: Traditional Methods, Digital Contraceptive Apps, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels
4) By End User: Male, Female

Subsegments:
1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants
2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24197&type=smp

Which Top Companies are Driving Growth in the Contraceptive Drugs And Devices Market?
Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.

Which Regions Will Dominate the Contraceptive Drugs And Devices Market Through 2029?
North America was the largest region in the contraceptive drugs and devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24197

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.